News
07
2025-01
BrosMed Medical Obtains CE Mark for RevoEdge™ High-Pressure Cutting Balloon
January 7, 2024 — BrosMed Medical is pleased to announce that it has obtained CE Marking under the European Medical Device Regulation (MDR) for the RevoEdge™ High-Pressure Coronary Cutting Balloon. Designed to support the treatment of complex coronary lesions, RevoEdge™ combines advanced cutting performance with excellent crossability.
2025-01-07
15
2024-08
Meet BrosMed at ESC Congress 2024
BrosMed Medical is delighted to participate in the ESC Congress 2024 from August 30th to September 2nd in London, UK.
2024-08-15
01
2024-08
BrosMed Medical Announces Scott J. Addonizio as Chief Operating Officer
August 1, 2024 — BrosMed Medical is pleased to announce the appointment of Scott J. Addonizio as its Chief Operating Officer (COO), effective immediately.
2024-08-01
27
2024-05
BrosMed Announced CE MDR Approval of New Generation PTA SC Balloon Dilatation Catheters
May 27, 2024 — BrosMed announced that it has received certification under the European Medical Device Regulation (MDR) for its new-generation PTA SC Balloon Dilatation Catheters, marketed under the brand names Polux™ Pro 014, Minerva™ Pro 018, and Atropos™ Pro 035.
2024-05-27
09
2023-11
Cordis and BrosMed launched a ceremony for the localization strategy at CIIE China
The 6th China International Import Expo (CIIE) officially opened in Shanghai on November 5, 2023. As one of the world's largest import-themed exhibitions, the CIIE brought together exhibitors and enterprises from around the globe to promote international trade, investment, and economic cooperation.
2023-11-09
19
2023-10
The 37th Annual Meeting of the European Society for Vascular Surgery 2023 (ESVS 2023) was successfully held in Belfast, United Kingdom, from September 26 to 29.
2023-10-19
21
2023-06
BrosMed Medical Earned MDSAP Certification
Dongguan, June 21, 2023 — BrosMed today announced that it has received Medical Device Single Audit Program (MDSAP) certification, demonstrating that a single regulatory audit of BrosMed’s quality management system satisfies the requirements of multiple regulatory jurisdictions participating in the program.
2023-06-21
12
2023-04
BrosMed’s POT™ NC PTCA Balloon Dilatation Catheter Received FDA 510(k) Clearance
April 12, 2023 — BrosMed Medical announced that it has received FDA 510(k) clearance for the POT™ NC PTCA Balloon Dilatation Catheter, the world’s first dedicated balloon designed for the proximal optimization technique (POT) and distal optimization technique (DOT) in bifurcation stenting.
2023-04-12
